Rapamycin induces differentiation of glioma stem/progenitor cells by activating autophagy

Chinese Journal of Cancer

Volumn 30, Issue 10, 2011, Pages 712-720

  Zhuang, Wen Zhuo ^a   Long, Lin Mei ^a   Ji, Wen Jun ^a   Liang, Zhong Qin ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

Autophagy; Differentiation; Glioma stem progenitor cells; Rapamycin

Indexed keywords

RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CANCER STEM CELL; CELL DIFFERENTIATION; CELL RENEWAL; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; GLIOMA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING;

ADENINE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; AUTOPHAGY; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; HUMANS; LEUCINE; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASTIC STEM CELLS; RNA, MESSENGER; SIROLIMUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80054748840     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.011.10234     Document Type: Article

References (28)

1. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells[J]. Nature, 2004,432(7015):396-401.
2. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas [J]. N Engl J Med, 2005,353(8):811-822.
3. Anido J, Saez-Borderias A, Gonzalez-Junca A, et al. TGF-beta receptor inhibitors target the CD44 (high)/Id1 (high) glioma initiating cell population in human glioblastoma [J]. Cancer Cell, 2010,18(6):655-668.
4. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J]. Nature, 2006,444(7120):756-760.
5. Ikushima H, Todo T, Ino Y, et al. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-in itiating cells through Sryrelated HMG-box factors [J]. Cell Stem Cell, 2009,5(5):504-514.
6. Lee J, Kotliarova S, Kotliarov Y, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines [J]. Cancer Cell, 2006,9(5): 391-403.
7. Lee J, Son MJ, Woolard K, et al. Epigenetic-m ediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-in itiating cells [J]. Cancer Cell, 2008,13(1):69-80.
8. Penuelas S, Anido J, Prieto-Sanchez RM, et al. TGF-beta increases glioma-in itiating cell self-re newal through the induction of LIF in human glioblastoma [J]. Cancer Cell, 2009,15(4):315-327.
9. Piccirillo SG, Reynolds BA, Zanetti N, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-in itiating cells [J]. Nature, 2006,444(7120):761-765.
10. Ricci-Vitiani L, Pallini R, Biffoni M, et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-lik e cells [J]. Nature, 2011,468(7325):824-828.
11. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells [J]. Nat Rev Cancer, 2006,6(6):425-436.
12. Wang J, Wakeman TP, Lathia JD, et al. Notch promotes radioresistance of glioma stem cells[J]. Stem Cells, 2010,28 (1):17-28.
13. Zheng H, Ying H, Yan H, et al. P53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation [J]. Nature, 2008,455(7216):1129-1133.
14. Huang Q, Zhang QB, Dong J, et al. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained longterm in vitro [J]. BMC Cancer, 2008,8:304-314.
15. Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing [J]. EMBO J, 2000,19 (21):5720-5728.
16. Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy[J]. Int J Biochem Cell Biol, 2004,36 (12):2503-2518.
17. Taipale J, Beachy PA. The Hedgehog and Wnt signaling pathways in cancer [J]. Nature, 2001,411(6835):349-354.
18. Kondo Y, Kanzawa T, Sawaya R, et al. The role of autophagy in cancer development and response to therapy [J]. Nat Rev Cancer, 2005,5(9):726-734.
19. Levine B. Cell biology: autophagy and cancer[J]. Nature, 2007,446(7137):745-747.
20. Zhuang W, Li B, Long L, et al. Knockdown of the DNAdependent protein kinase catalytic subunit radiosensitizes glioma-in itiating cells by inducing autophagy [J]. Brain Res, 2011,1371:7-15.
21. Yang YP, Liang ZQ, Gu ZL, et al. Molecular mechanism and regulation of autophagy [J]. Acta Pharmacol Sin, 2005,26(12): 1421-1434.
22. Yan CH, Liang ZQ, Gu ZL, et al. Contributions of autophagic and apoptotic mechanisms to CrTX-in duced death of K562 cells [J]. Toxicon, 2006,47(5):521-530.
23. Li J, Qin Z, Liang Z. The prosurvival role of autophagy in Resveratrol-in duced cytotoxicity in human U251 glioma cells [J]. BMC Cancer, 2009,9:215-223.
24. Zhuang W, Qin Z, Liang Z. The role of autophagy in sensitizing malignant glioma cells to radiation therapy[J]. Acta Biochim Biophys Sin (Shanghai), 2009,41(5):341-351.
25. Yoshimori T. Autophagy: paying Charon's toll[J]. Cell, 2007,128(5):833-836.
26. Zeng M, Zhou JN. Roles of autophagy and mTOR signaling in neuronal differentiation of mouse neuroblastoma cells [J]. Cell Signal, 2008,20(4):659-665.
27. Asanuma K, Tanida I, Shirato I, et al. MAP-LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis [J]. Faseb J, 2003,17(9):1165-1167.
28. Levine BK, lionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy [J]. Dev Cell, 2004,6(4):463-477.